Ken Cranwill Resigns from Universal Ibogaine Inc.'s Board; Company Settles Debt with Share Issuance

Calgary, AB — July 8, 2025 — NewsWall — Universal Ibogaine Inc. (TSXV:IBO) announced the resignation of Ken Cranwill from its Board of Directors. Cranwill is leaving to concentrate on other business ventures.

Nick Karos, CEO and Director, thanked Cranwill for his service. The company also received TSX Venture Exchange approval to settle $106,200 of arrears consulting fees owed to Karos. Universal Ibogaine will issue 4,248,000 common shares at $0.025 per share to settle the debt. Following the issuance, the total outstanding common shares will be 312,858,516.

Universal Ibogaine is focused on addiction treatment using medicalized ibogaine. The company is planning a Canadian clinical trial for opioid use disorder and developing a holistic addiction treatment protocol at its Kelburn Recovery Centre near Winnipeg, Manitoba.

Nick Karos, CEO Universal Ibogaine Inc. 612-309-3527 Nick.Karos@universalibogaine.com

Source: Universal Ibogaine Inc.